The serological hallmark of the altered immunological status of patients with systemic lupus erythematosus (SLE) is the presence of antibodies in the sera of these patients to variety of autoantigens, most notably DNA and complexes of DNA-histone. Our laboratory has engaged in a study of immune responses in SLE patients to a family of antigens which do not contain DNA but are small RNA protein particles. Precipitating antibodies to one or more of these antigens occur in 80% of unselected SLE patients. All of these antigens have been purified to chemical homogeneity by affinity chromatography methods and sensitive ELISA techniques adapted to measurement of specific antibodies. This proposal aims to study several aspects of the immune response to these RNAprotein antigens as well as some studies of idiotypes on anti-DNA molecules in SLE patients. The problems to be studied are (1) an analysis of the cellular basis of the association of the response to the antigen pairs Ro/SSA, La/SSB and nRNP, Sm. (2) Examination of anti-Ro/SSA antibodies from different SLE subsets for the presence of distinguishing molecular characteristics, including specific idiotype markers. (3) Search for evidence of participation of antibodies to the RNAprotein antigens in circulating immune complexes in SLE and Sjogren's patients. (4) Study of shared idiotypes on anti-DNA molecules in SLE sera and the study of autoanti-idiotypes in individual SLE patients studied longitudinally. (5) Age related production of specific autoantibodies in the SLE population. (6) Search for Ro/SSA antigen in neonatal skin and conducting tissue of the heart. Such studies should enhance our understanding of the production of these antibodies, their role in disease expression, and their relationship to the basic defect in immunoregulation characteristic of these patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR031133-11
Application #
3155980
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1981-12-01
Project End
1996-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
11
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Zhang, W; Winkler, T; Kalden, J R et al. (2001) Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with Systemic lupus erythematosus. Scand J Immunol 53:192-7
Handwerger, B S; Storrer, C E; Wasson, C S et al. (1999) Further characterization of the autoantibody response of Palmerston North mice. J Clin Immunol 19:45-57
Koscec, M; Koren, E; Wolfson-Reichlin, M et al. (1997) Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 159:2033-41
Taylor-Albert, E; Reichlin, M; Toews, W H et al. (1997) Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis, and management. Pediatrics 99:733-5
Nickerson-Nutter, C L; Medvedeff, E D (1996) The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation. Arthritis Rheum 39:515-21
Tsuzaka, K; Leu, A K; Frank, M B et al. (1996) Lupus autoantibodies to double-stranded DNA cross-react with ribosomal protein S1. J Immunol 156:1668-75
Tsuzaka, K; Winkler, T H; Kalden, J R et al. (1996) Autoantibodies to double-stranded (ds)DNA immunoprecipitate 18S ribosomal RNA by virtue of their interaction with ribosomal protein S1 and suppress in vitro protein synthesis. Clin Exp Immunol 106:504-8
Zhang, W; Reichlin, M (1996) Some autoantibodies to Ro/SS-A and La/SS-B are antiidiotypes to anti-double-stranded DNA. Arthritis Rheum 39:522-31
Zhang, W; Reichlin, M (1995) IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera. Clin Immunol Immunopathol 74:70-6
Reichlin, M (1995) Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopathol 76:215-9

Showing the most recent 10 out of 35 publications